Equillium (EQ) Interest Coverage Ratio (QoQ) (2018 - 2026)
Equillium (EQ) Interest Coverage Ratio (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Equillium | 258.99 Mn | 258.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.48% |
| Dec 31, 2025 | -9,634.85% |
| Mar 31, 2025 | -141.90% |
| Dec 31, 2024 | -3,061.36% |
| Sep 30, 2024 | 34.76% |
| Jun 30, 2024 | -800.18% |
| Sep 30, 2023 | -585.34% |
| Jun 30, 2023 | 82.33% |
| Mar 31, 2023 | -334.99% |
| Dec 31, 2022 | 115.20% |
| Sep 30, 2022 | -4.63% |
| Jun 30, 2022 | 5.81% |
| Mar 31, 2022 | -28.84% |
| Dec 31, 2021 | -3,475.42% |
| Sep 30, 2021 | 27.16% |
| Jun 30, 2021 | -97.83% |
| Mar 31, 2021 | 97.67% |
| Dec 31, 2020 | -2,966.95% |
| Sep 30, 2020 | 87.66% |
| Jun 30, 2020 | 68.55% |